These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 28087483)

  • 21. Human Induced Pluripotent Stem Cell-Derived Non-Cardiomyocytes Modulate Cardiac Electrophysiological Maturation Through Connexin 43-Mediated Cell-Cell Interactions.
    Biendarra-Tiegs SM; Clemens DJ; Secreto FJ; Nelson TJ
    Stem Cells Dev; 2020 Jan; 29(2):75-89. PubMed ID: 31744402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnesium lithospermate B enhances the potential of human-induced pluripotent stem cell-derived cardiomyocytes for myocardial repair.
    Fan C; Qin K; Iroegbu CD; Xiang K; Gong Y; Guan Q; Wang W; Peng J; Guo J; Wu X; Yang J
    Chin Med J (Engl); 2024 Aug; 137(15):1857-1869. PubMed ID: 38221772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-throughput 3D Spheroid Formation and Effective Cardiomyocyte Differentiation from Human iPS Cells Using the Microfabric Vessels EZSPHERE
    Miwa T; Idiris A; Kumagai H
    Bio Protoc; 2021 Nov; 11(21):e4203. PubMed ID: 34859118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting HIF-1α in combination with PPARα activation and postnatal factors promotes the metabolic maturation of human induced pluripotent stem cell-derived cardiomyocytes.
    Gentillon C; Li D; Duan M; Yu WM; Preininger MK; Jha R; Rampoldi A; Saraf A; Gibson GC; Qu CK; Brown LA; Xu C
    J Mol Cell Cardiol; 2019 Jul; 132():120-135. PubMed ID: 31082397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells.
    Lundy SD; Zhu WZ; Regnier M; Laflamme MA
    Stem Cells Dev; 2013 Jul; 22(14):1991-2002. PubMed ID: 23461462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human induced pluripotent stem cell-derived three-dimensional cardiomyocyte tissues ameliorate the rat ischemic myocardium by remodeling the extracellular matrix and cardiac protein phenotype.
    Yokoyama J; Miyagawa S; Akagi T; Akashi M; Sawa Y
    PLoS One; 2021; 16(3):e0245571. PubMed ID: 33720933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
    Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
    Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of functional cardiomyocytes and cardiac tissue from human induced pluripotent stem cells for regenerative therapy.
    Tani H; Tohyama S; Kishino Y; Kanazawa H; Fukuda K
    J Mol Cell Cardiol; 2022 Mar; 164():83-91. PubMed ID: 34822838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymosin β4 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell-derived cardiomyocytes in a porcine model of acute myocardial infarction.
    Tan SH; Loo SJ; Gao Y; Tao ZH; Su LP; Wang CX; Zhang SL; Mu YH; Cui YH; Abdurrachim D; Wang WH; Lalic J; Lim KC; Bu J; Tan RS; Lee TH; Zhang J; Ye L
    Theranostics; 2021; 11(16):7879-7895. PubMed ID: 34335970
    [No Abstract]   [Full Text] [Related]  

  • 30. Maturation of hiPSC-derived cardiomyocytes promotes adult alternative splicing of SCN5A and reveals changes in sodium current associated with cardiac arrhythmia.
    Campostrini G; Kosmidis G; Ward-van Oostwaard D; Davis RP; Yiangou L; Ottaviani D; Veerman CC; Mei H; Orlova VV; Wilde AAM; Bezzina CR; Verkerk AO; Mummery CL; Bellin M
    Cardiovasc Res; 2023 Mar; 119(1):167-182. PubMed ID: 35394010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A three-dimensional culture system for generating cardiac spheroids composed of cardiomyocytes, endothelial cells, smooth-muscle cells, and cardiac fibroblasts derived from human induced-pluripotent stem cells.
    Kahn-Krell A; Pretorius D; Guragain B; Lou X; Wei Y; Zhang J; Qiao A; Nakada Y; Kamp TJ; Ye L; Zhang J
    Front Bioeng Biotechnol; 2022; 10():908848. PubMed ID: 35957645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of Human Induced Pluripotent Stem Cell Technology for Cardiovascular Regenerative Pharmacology.
    Majid QA; Orsolits B; Pohjolainen L; Kovács Z; Földes G; Talman V
    Methods Mol Biol; 2022; 2454():163-196. PubMed ID: 33755910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional Effects of a Tissue-Engineered Cardiac Patch From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Rat Infarct Model.
    Wendel JS; Ye L; Tao R; Zhang J; Zhang J; Kamp TJ; Tranquillo RT
    Stem Cells Transl Med; 2015 Nov; 4(11):1324-32. PubMed ID: 26371342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Scalable Approach Reveals Functional Responses of iPSC Cardiomyocyte 3D Spheroids.
    Burnham MP; Harvey R; Sargeant R; Fertig N; Haddrick M
    SLAS Discov; 2021 Mar; 26(3):352-363. PubMed ID: 33283596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology.
    Sharma P; Gentile C
    J Vis Exp; 2021 Jan; (167):. PubMed ID: 33554972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mature human induced pluripotent stem cell-derived cardiomyocytes promote angiogenesis through alpha-B crystallin.
    Tanaka Y; Kadota S; Zhao J; Kobayashi H; Okano S; Izumi M; Honda Y; Ichimura H; Shiba N; Uemura T; Wada Y; Chuma S; Nakada T; Tohyama S; Fukuda K; Yamada M; Seto T; Kuwahara K; Shiba Y
    Stem Cell Res Ther; 2023 Sep; 14(1):240. PubMed ID: 37679796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amniotic membrane as novel scaffold for human iPSC-derived cardiomyogenesis.
    Parveen S; Singh SP; Panicker MM; Gupta PK
    In Vitro Cell Dev Biol Anim; 2019 Apr; 55(4):272-284. PubMed ID: 30798515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of appropriate fatty acid formulations to raise the contractility of constructed myocardial tissues.
    Yoshida A; Sekine W; Homma J; Sekine H; Itoyama YY; Sasaki D; Matsuura K; Kobayashi E; Shimizu T
    Regen Ther; 2022 Dec; 21():413-423. PubMed ID: 36248630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conditioning of hiPSC-derived cardiomyocytes using surface topography obtained with high throughput technology.
    Cortella LRX; Cestari IA; Lahuerta RD; Araña MC; Soldera M; Rank A; Lasagni AF; Cestari IN
    Biomed Mater; 2021 Sep; 16(6):. PubMed ID: 34412045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of a human iPSC-derived cardiomyocyte/fibroblast engineered heart tissue model.
    Cumberland MJ; Euchner J; Azad AJ; T N Vo N; Kirchhof P; Holmes AP; Denning C; Gehmlich K
    F1000Res; 2023; 12():1224. PubMed ID: 38298530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.